https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Kidneys-MS.jpg

Urology Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Stone Management Devices, BPH Treatment Devices, and 7 more

  • Year: 2022
  • Scope: 10 Years
  • Region: United States
  • Published Date: 11/09/2021
  • Type: MedSuite

Overall, the U.S. urology market was valued at over $3.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 4.3% to reach $5 billion by 2028.

As the U.S. urology market demand continues to undergo consolidation with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing organizations (GPOs) as well as reimbursement cuts across the urology space, the ASPs are expected to remain under significant pressure, negatively impacting the future growth of the market.

In 2021, the largest segment of the total urological device market was urinary incontinence. Growth of this segment is primarily driven by the urinary catheter segment and the high-volume use of urinary catheters. The second-largest segment of the total urological device market in 2021 was BPH treatment devices. Growth of this segment is primarily driven by the UroLift® market, which has experienced rapid growth since NeoTract launched the UroLift® system in 2013.

MARKET REPORT DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

COVID-19 IMPACT ON THE U.S. UROLOGY MARKET

Overall, the negative impact of the COVID-19 pandemic on the urological device market seems to vary depending on the severity of each case. Erectile dysfunction (ED), benign prostate hyperplasia (BPH) and stone management treatments are elective procedures. As such, these market segments experienced the greatest decline. However, urgent treatments, as demonstrated in the prostate cancer treatment device market, were less impacted by the COVID-19 pandemic.

U.S. UROLOGY MARKET SHARE INSIGHTS

Overall, within the U.S. Urology market there are three dominant competitors: Boston Scientific, Becton Dickinson, and Coloplast.U.S. UR 22In 2021, the leading competitor in the urological device market was Boston Scientific. The company held the leading positions in the stone management device segment, prostate cancer device segment and men’s reproductive health segment. The company also held notable positions in all remaining segments, with the exception of the urodynamic equipment market, from which the company was absent.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

  • Urinary Incontinence Devices Market – MedCore – The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents and incontinence management devices.
  • Stone Management Devices – MedCore – The total market for stone management devices includes ESWL capital equipment, pneumatic, ultrasonic, and combination lithotripsy capital equipment, Holmium and Thulium laser capital equipment and fibers, stone fragment retrieval devices, access sheaths and ureteral stents.
  • BPH Treatment Devices – MedCore – The BPH treatment device market includes devices used for TURP, TUMT, TUNA, prostatic stent, laser BPH, UroLift®Rez?m® and iTind® procedures. In 2021, the largest segment in the BPH treatment device market was the UroLift® market.
  • Urological Endoscope – MedCore – The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.
  • Prostate Cancer Treatment Devices – MedCore – The prostate cancer treatment device market includes brachytherapy devices and cryotherapy ablation devices.
  • Urodynamic Equipment Market – MedCore – The market for urodynamic equipment includes capital equipment and disposables. As these procedures can be performed in both hospitals and outpatient offices, the capital equipment market is segmented into those sold at hospitals versus those sold at outpatient offices.
  • Nephrostomy Devices – MedCore – The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.
  • Men’s Reproductive Health Market – MedCore – The total market for men’s reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices and vacuum assisted erectile dysfunction devices.
  • Urinary Guidewire Market – MedCore – The market for guidewires includes all guidewires to be used in urological procedures.

Research Scope Summary

Report Attribute Details
Regions United States
Base Year 2021
Forecast 2022-2028
Historical Data 2018-2021
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

FREE Sample Report

TABLE OF CONTENTS I LIST OF FIGURES  XVI LIST OF CHARTS  XXVIII EXECUTIVE SUMMARY US UROLOGICAL DEVICE MARKET OVERVIEW COMPETITIVE ANALYSIS
  • MARKET TRENDS
  • MARKET DEVELOPMENTS
  • PROCEDURE NUMBERS
  • PROCEDURE CODES INVESTIGATED
  • MARKETS INCLUDED
  • KEY REPORT UPDATES
  • VERSION HISTORY
  • RESEARCH METHODOLOGY
  • IMPACT OF COVID-19 ON THE US UROLOGICAL DEVICE MARKET
  • 21 INTRODUCTION
  • 22 ANALYSIS BY MARKET SEGMENT
  • DISEASE OVERVIEW
  • 31 BASIC ANATOMY
  • 32 DISEASE TREATMENT AND DIAGNOSTICS
  • 33 PATIENT DEMOGRAPHICS
  • PRODUCT ASSESSMENT
  • INTRODUCTION
  • 42 PRODUCT PORTFOLIOS
  • 43 REGULATORY ISSUES AND RECALLS
  • US UROLOGICAL DEVICE MARKET OVERVIEW
  • 51 MARKET OVERVIEW & TREND ANALYSIS
  • 52 DRIVERS AND LIMITERS
  • 53 COMPETITIVE MARKET SHARE ANALYSIS
  • 54 MERGERS AND ACQUISITIONS
  • 55 COMPANY PROFILES
  • PROCEDURE NUMBERS
  • 61 PROCEDURE CODES INVESTIGATED
  • 62 PROCEDURE OVERVIEW
  • URINARY INCONTINENCE DEVICE MARKET
  • 71 INTRODUCTION
  • 72 MARKET OVERVIEW
  • 73 MARKET ANALYSIS AND FORECAST
  • 74 DRIVERS AND LIMITERS
  • 75 COMPETITIVE MARKET SHARE ANALYSIS
  • STONE MANAGEMENT DEVICE MARKET
  • 81 INTRODUCTION
  • 82 MARKET OVERVIEW
  • 83 MARKET ANALYSIS AND FORECAST
  • 84 DRIVERS AND LIMITERS
  • 85 COMPETITIVE MARKET SHARE ANALYSIS
  • BPH TREATMENT DEVICE MARKET
  • 91 INTRODUCTION
  • 92 MARKET OVERVIEW
  • 93 MARKET ANALYSIS AND FORECAST
  • 94 DRIVERS AND LIMITERS
  • 95 COMPETITIVE MARKET SHARE ANALYSIS
  • UROLOGICAL ENDOSCOPE MARKET
  • 101 INTRODUCTION
  • 102 MARKET OVERVIEW
  • 103 MARKET ANALYSIS AND FORECAST
  • 104 DRIVERS AND LIMITERS
  • 105 COMPETITIVE MARKET SHARE ANALYSIS
  • PROSTATE CANCER TREATMENT DEVICE MARKET
  • 111 INTRODUCTION
  • 112 MARKET OVERVIEW
  • 113 MARKET ANALYSIS AND FORECAST
  • 114 DRIVERS AND LIMITERS
  • 115 COMPETITIVE MARKET SHARE ANALYSIS
  • URODYNAMIC EQUIPMENT MARKET
  • 121 INTRODUCTION
  • 122 MARKET OVERVIEW
  • 123 MARKET ANALYSIS AND FORECAST
  • 124 DRIVERS AND LIMITERS
  • 125 COMPETITIVE MARKET SHARE ANALYSIS
  • NEPHROSTOMY DEVICE MARKET
  • 131 INTRODUCTION
  • 132 MARKET OVERVIEW
  • 133 MARKET ANALYSIS AND FORECAST
  • 134 DRIVERS AND LIMITERS
  • 135 COMPETITIVE MARKET SHARE ANALYSIS
  • MEN’S REPRODUCTIVE HEALTH MARKET
  • 141 INTRODUCTION
  • 142 MARKET OVERVIEW
  • 143 MARKET ANALYSIS AND FORECAST
  • 144 DRIVERS AND LIMITERS
  • 145 COMPETITIVE MARKET SHARE ANALYSIS
  • URINARY GUIDEWIRE MARKET
  • 151 INTRODUCTION
  • 152 MARKET ANALYSIS AND FORECAST
  • 153 DRIVERS AND LIMITERS
  • 154 COMPETITIVE MARKET SHARE ANALYSIS
  • ABBREVIATIONS
  • LIST OF FIGURES
[/logged_out]
The "Urological Devices Market " includes analysis on the following companies currently active in this market: Advanced Endoscopic Devices Cooper Surgical Aeromed Deroyal Angiodynamicss Direx Applied Medical Dornier MedTech AprioMed Dynarex Argon Medical Eckert & Ziegler BEBIG Ashlar EDAP TMS Augusta Medical Systems Electro Medical Systems Authentic Option Elekta BARD Galil Medical Best Medical GE Oncura BioDerm Healthtronics Biolitec Hollister Boston Scientific Innovaquartz BR Surgical IsoAid Calcura Technologies IsoRay Caldera Medical Karl Storz Cardinal Health LABORIE Coloplast Laser Peripheral Convergent Laser Technologies LISA Laser Cook Medical Lumenis *Not all companies may be currently active in every segment. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology